REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/01/2026
Back to search
Official data from USPTO
CYPEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/02/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
08/25/2004
Registration date
05/01/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2017
Last transaction
05/02/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Dundee, GB
Examiner
LE, KHANH M
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Cypex Limited
Cypex Limited
Representatives
Michele M. Glessner Alston & Bird LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
BIOCHEMICAL PREPARATIONSMONOCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USEPOLYCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USERECOMBINANT PROTEINENZYMESRECOMBINANT HUMAN ENZYMESRECOMBINANT HUMAN ENZYMES IN BACTERIARECOMBINANT HUMAN DRUG-METABOLIZING ENZYMESMETABOLITESALL FOR SCIENTIFIC OR RESEARCH USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR SCIENTIFIC OR RESEARCH USE; BACTERIAL PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; ASSAYS FOR SCIENTIFIC OR RESEARCH USE
Class 5
BIOCHEMICAL PREPARATIONS FOR MEDICAL OR VETERINARY USEMONOCLONAL ANTIBODIESPOLYCLONAL ANTIBODIESTAGGED ANTIBODIESRECOMBINANT PROTEINENZYMESRECOMBINANT HUMAN ENZYMESRECOMBINANT HUMAN ENZYMES IN BACTERIARECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; REAGENTS FOR USE IN DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR MEDICAL USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR MEDICAL USE; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR MEDICAL PURPOSES; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR PHARMACEUTICAL PURPOSES; ASSAYS FOR MEDICAL USE; BACTERIAL PRODUCTSBACTERIAL CULTURES FOR MEDICAL USE; BACTERIAL PREPARATIONS FOR MEDICAL USE; BACTERIAL VACCINES FOR MEDICAL USE; BACTERIAL MEMBRANES FOR MEDICAL USE; REAGENTS IN KIT FORM FOR MEDICAL USE
Class 42
SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF BIOTECHNOLOGYDRUG METABOLITE SYNTHESISHETEROLOGOUS PROTEIN EXPRESSIONIN VITRO DRUG METABOLISM SYSTEMSPRODUCTION OF RECOMBINANT PROTEINPRODUCTION OF RECOMBINANT HUMAN ENZYMESPRODUCTION OF RECOMBINANT HUMAN ENZYMES IN BACTERIAPRODUCTION OF RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; SCIENTIFIC RESEARCH CONSULTATION
Publications
History of USPTO decisions and trademark events.
32 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/10/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/10/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/10/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/10/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
04/18/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/01/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/27/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/26/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2012
E815
TEAS SECTION 8 & 15 RECEIVED
08/08/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2007
PUBO
PUBLISHED FOR OPPOSITION
02/13/2007
NPUB
NOTICE OF PUBLICATION
01/24/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/20/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/04/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2006
ALIE
ASSIGNED TO LIE
12/04/2006
PAPER RECEIVED
11/13/2006
CNSI
INQUIRY AS TO SUSPENSION MAILED
05/12/2006
CNSI
SUSPENSION INQUIRY WRITTEN
05/12/2006
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/11/2006
CRML
CORRESPONDENCE MAILED
10/27/2005
CNSL
SUSPENSION LETTER WRITTEN
10/27/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/06/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2005
PAPER RECEIVED
09/28/2005
CNRT
NON-FINAL ACTION MAILED
03/28/2005
CNRT
NON-FINAL ACTION WRITTEN
03/25/2005
DOCK
ASSIGNED TO EXAMINER
03/25/2005
NWAP
NEW APPLICATION ENTERED
09/03/2004
Continuous trademark protection
Get notified about every new filing that threatens CYPEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.